Genomic features of exceptional response in vemurafenib +/- cobimetinib-treated patients with BRAF(V600)-mutated metastatic melanoma

DSpace Repository

Genomic features of exceptional response in vemurafenib +/- cobimetinib-treated patients with BRAF(V600)-mutated metastatic melanoma

Author: Yan, Yibing; Wongchenko, Matthew J.; Robert, Caroline; Larkin, James; Ascierto, Paolo A.; Dreno, Brigitte; Maio, Michele; Garbe, Claus; Chapman, Paul B.; Sosman, Jeffrey A.; Shi, Zhen; Koeppen, Hartmut; Hsu, Jessie J.; Chang, Ilsung; Caro, Ivor; Rooney, Isabelle; McArthur, Grant A.; Ribas, Antoni
Tübinger Autor(en):
Garbe, Claus
Published in: Clinical Cancer Research (2019), Bd. 25, H. 11, S. 3239-3246
Verlagsangabe: Amer Assoc Cancer Research
Language: English
Full text: http://dx.doi.org/10.1158/1078-0432.CCR-18-0720
ISSN: 1557-3265
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)